Fibrocystic breasts
შეჯამება
განსაზღვრება
ანამნეზი და გასინჯვა
ძირითადი დიაგნოსტიკური ფაქტორები
- mastalgia
- diffuse symmetric lumpiness through both breasts
სხვა დიაგნოსტიკური ფაქტორები
- age 30 to 50 years
- nipple discharge
- palpable breast mass
რისკფაქტორები
- late-onset menopause
- later age at first childbirth
- nulliparity
- obesity
- estrogen replacement therapy
დიაგნოსტიკური კვლევები
1-ად შესაკვეთი გამოკვლევები
- mammography
- breast ultrasound
გასათვალისწინებელი კვლევები
- cyst aspiration
- breast biopsy
მკურნალობის ალგორითმი
mastalgia
nipple discharge
კონტრიბუტორები
ავტორები
Sonia Sugg, MD
Professor of Surgery
Division of Surgical Oncology and Endocrine Surgery
University of Iowa Hospitals and Clinics
Iowa City
IA
გაფრთხილება:
SS declares that she has no competing interests.
Ingrid Lizarraga, MBBS, FACS
Clinical Associate Professor
Division of Surgical Oncology and Endocrine Surgery
University of Iowa Hospitals and Clinics
Iowa City
IA
გაფრთხილება:
IL declares that she has no competing interests.
მადლიერება
Dr Sonia Sugg and Dr Ingrid Lizarraga would like to gratefully acknowledge Dr Sophia Fu, Dr Sarah E. Colwick, Dr Hernan I. Vargas, Dr Carol Scott-Connor, Dr Anjali Thawani, and Dr Jesse Dirksen, the previous contributors to this topic. SEC, HIV, CSC, AT and JD declare that they have no competing interests.
გაფრთხილება:
SF, SEC, HIV, CSC, AT, and JD declared that they had no competing interests.
რეცენზენტები
Fred Dirbas, MD
Assistant Professor of Surgical Oncology
Stanford University
Stanford
CA
გაფრთხილება:
FD declares that he has no competing interests.
Justin Stebbing, MA, MRCP, MRCPath, PhD
Consultant Medical Oncologist/Senior Lecturer
Imperial College Healthcare NHS Trust
Charing Cross Hospital
London
UK
利益声明
JS declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
参考文献
关键文献
Marchant DJ. Benign breast disease. Obstet Gynecol Clin North Am. 2002 Mar;29(1):1-20. 摘要
Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005 Jul 21;353(3):275-85. 摘要
Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Eng J Med.1982 Oct 14;307(16):1010-4. 摘要
Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985 Jan 17;312(3):146-51. 摘要
Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.全文 摘要
参考文献
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
鉴别诊断
- Chest wall pain
- Costochondritis
- Fibroadenoma
更多 鉴别诊断指南
- Screening for breast cancer: recommendation statement
- ACR appropriateness criteria: palpable breast masses
更多 指南患者教育信息
Breast cancer: DCIS (very early breast cancer) in women
Breast cancer, locally advanced: what is it?
更多 患者教育信息
登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明